HIND
Price
$2.24
Change
-$0.02 (-0.88%)
Updated
Jul 13 closing price
Capitalization
15.72M
31 days until earnings call
Intraday BUY SELL Signals
MTNB
Price
$0.49
Change
-$0.27 (-35.53%)
Updated
Jul 13, 04:59 PM (EDT)
Capitalization
3.07M
Intraday BUY SELL Signals
Interact to see
Advertisement

HIND vs MTNB

HIND vs MTNB Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
HIND vs. MTNB commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HIND is a Hold and MTNB is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 14, 2026
Stock price -- (HIND: $2.26 vs. MTNB: $0.76)
Brand notoriety: HIND and MTNB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: HIND: 45% vs. MTNB: 718%
Market capitalization -- HIND: $15.72M vs. MTNB: $3.07M
HIND [@Biotechnology] is valued at $15.72M. MTNB’s [@Biotechnology] market capitalization is $3.07M. The market cap for tickers in the [@Biotechnology] industry ranges from $121.89B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HIND’s FA Score shows that 0 FA rating(s) are green whileMTNB’s FA Score has 1 green FA rating(s).

  • HIND’s FA Score: 0 green, 5 red.
  • MTNB’s FA Score: 1 green, 4 red.
According to our system of comparison, MTNB is a better buy in the long-term than HIND.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HIND’s TA Score shows that 6 TA indicator(s) are bullish while MTNB’s TA Score has 6 bullish TA indicator(s).

  • HIND’s TA Score: 6 bullish, 2 bearish.
  • MTNB’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, HIND is a better buy in the short-term than MTNB.

Price Growth

HIND (@Biotechnology) experienced а -1.74% price change this week, while MTNB (@Biotechnology) price change was +19.20% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.13%. For the same industry, the average monthly price growth was +7.30%, and the average quarterly price growth was +1806.57%.

Reported Earning Dates

HIND is expected to report earnings on Aug 13, 2026.

Industries' Descriptions

@Biotechnology (-3.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HIND($15.7M) has a higher market cap than MTNB($3.08M). MTNB YTD gains are higher at: -18.089 vs. HIND (-34.884). MTNB has higher annual earnings (EBITDA): -6.55M vs. HIND (-11.07M). HIND has more cash in the bank: 8.8M vs. MTNB (2.4M). HIND has less debt than MTNB: HIND (22.5K) vs MTNB (1.19M). HIND has higher revenues than MTNB: HIND (153K) vs MTNB (0).
HINDMTNBHIND / MTNB
Capitalization15.7M3.08M511%
EBITDA-11.07M-6.55M169%
Gain YTD-34.884-18.089193%
P/E RatioN/AN/A-
Revenue153K0-
Total Cash8.8M2.4M367%
Total Debt22.5K1.19M2%
FUNDAMENTALS RATINGS
HIND vs MTNB: Fundamental Ratings
HIND
MTNB
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
37
Fair valued
23
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
5946
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MTNB's Valuation (23) in the Biotechnology industry is in the same range as HIND (37) in the null industry. This means that MTNB’s stock grew similarly to HIND’s over the last 12 months.

MTNB's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as HIND (100) in the null industry. This means that MTNB’s stock grew similarly to HIND’s over the last 12 months.

MTNB's SMR Rating (100) in the Biotechnology industry is in the same range as HIND (100) in the null industry. This means that MTNB’s stock grew similarly to HIND’s over the last 12 months.

MTNB's Price Growth Rating (46) in the Biotechnology industry is in the same range as HIND (59) in the null industry. This means that MTNB’s stock grew similarly to HIND’s over the last 12 months.

MTNB's P/E Growth Rating (100) in the Biotechnology industry is in the same range as HIND (100) in the null industry. This means that MTNB’s stock grew similarly to HIND’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
HINDMTNB
RSI
ODDS (%)
N/A
Bullish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 4 days ago
77%
Momentum
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 4 days ago
77%
MACD
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 4 days ago
72%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
74%
Bearish Trend 4 days ago
90%
Advances
ODDS (%)
Bullish Trend 4 days ago
85%
Bullish Trend 4 days ago
80%
Declines
ODDS (%)
Bearish Trend 20 days ago
90%
Bearish Trend 6 days ago
90%
BollingerBands
ODDS (%)
N/A
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
HIND
Daily Signal:
Gain/Loss:
MTNB
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FANG191.608.21
+4.48%
Diamondback Energy
TPST0.980.01
+1.08%
Tempest Therapeutics Inc
MRP28.17-0.20
-0.70%
Millrose Properties Inc
KURA10.91-0.54
-4.72%
Kura Oncology
SLNH1.12-0.14
-11.11%
Soluna Holdings

HIND and

Correlation & Price change

A.I.dvisor indicates that over the last year, HIND has been loosely correlated with PGEN. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if HIND jumps, then PGEN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HIND
1D Price
Change %
HIND100%
-0.88%
PGEN - HIND
46%
Loosely correlated
-2.82%
MTNB - HIND
38%
Loosely correlated
-36.45%
IMMP - HIND
36%
Loosely correlated
+7.52%
ONCY - HIND
31%
Poorly correlated
+4.69%
PHAT - HIND
30%
Poorly correlated
-13.44%
More

MTNB and

Correlation & Price change

A.I.dvisor indicates that over the last year, MTNB has been loosely correlated with HIND. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if MTNB jumps, then HIND could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MTNB
1D Price
Change %
MTNB100%
-36.45%
HIND - MTNB
38%
Loosely correlated
-0.88%
SPRC - MTNB
35%
Loosely correlated
-4.89%
AXON - MTNB
34%
Loosely correlated
-3.32%
VKTX - MTNB
32%
Poorly correlated
-1.90%
TPST - MTNB
32%
Poorly correlated
+1.08%
More